Journal article
Next-generation rotavirus vaccines: important progress but work still to be done
Julie Bines, Karen Kotloff
Lancet Infectious Diseases | Elsevier | Published : 2020
Grants
Funding Acknowledgements
JEB is lead of the RV3 Rotavirus Program at Murdoch Children's Research Institute (MCRI); MCRI is providing RV3-BB vaccine for a future clinical trial of parenteral trivalent P2-VP8 vaccine sponsored by PATH. KLK declares no competing interests.